Liraglutide vs. lixisenatide in obese type 2 diabetes mellitus patients: What effect should we expect in routine clinical practice?
| Autor: | Moreno-Fernandez, Jesus ⁎, Garcia-Seco, Jose Alberto, Seco Segura, Angela Maria, Garcia-Seco, Fernando, Rozas Moreno, Pedro Jesus, Aguirre Sanchez-Covisa, Miguel |
|---|---|
| Zdroj: | In Primary Care Diabetes February 2020 14(1):68-74 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect